Singapore scientists identify potential new biomarker to better personalize cancer therapy

(Duke-NUS Medical School) Testing for mutations in RNF43, a protein that affects key cancer cell-growth pathway Wnt, gives clinicians actionable insights to tailor treatments better.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news